NEUREKA

A smart, hybrid neural-silico-computo device for drug discovery

A visionary and innovative hybrid technology, whereby nanoelectrodes and sophisticated computational models of neuronal circuits are combined to readout and manipulate activity/connectivity in cultured neuronal networks of Alzheimer’s disease, with subcellular accuracy

An H2020 Future and Emerging Technology


NEUREKA  merges advanced computational modelling and high throughput nanoelectrodes into a powerful hybrid. The proposed merge  allows the brain-mimicking control of activity and the realistic modelling of neural diseases in culture, thus leading the way for a new generation of dish trials

Find out more